Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis: a rare adverse event?
Parekh
Ketna
K
Department of Rheumatology, Immunology and Allergy, Christchurch Hospital, Christchurch, New Zealand.
Ching
Daniel
D
Rahman
Mahboob U
MU
Stamp
Lisa K
LK
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; C529000:golimumab